Loading…

Anxiolytic–like activity of 5–methoxyflavone in mice with involvement of GABAergic and serotonergic systems - in vivo and in silico evidences

Anxiety disorders are common worldwide and novel compounds are investigated for anxiolytic effect. A few studies have demonstrated the anxiolytic-like activity of natural and synthetic flavonoids. 5-methoxyflavone, a synthetic flavone derivative, has been reported to exhibit central nervous system d...

Full description

Saved in:
Bibliographic Details
Published in:European neuropsychopharmacology 2020-07, Vol.36, p.100-110
Main Authors: Shanmugasundaram, Jaikumar, Subramanian, Viswanathan, Nadipelly, Jagan, Kathirvelu, Parimala, Sayeli, Vijaykumar, Cheriyan, Binoy Varghese
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c348t-3aee607c3efafd597597167139a25b2d59fa30f9cb230bfbdeeba572f4295363
cites cdi_FETCH-LOGICAL-c348t-3aee607c3efafd597597167139a25b2d59fa30f9cb230bfbdeeba572f4295363
container_end_page 110
container_issue
container_start_page 100
container_title European neuropsychopharmacology
container_volume 36
creator Shanmugasundaram, Jaikumar
Subramanian, Viswanathan
Nadipelly, Jagan
Kathirvelu, Parimala
Sayeli, Vijaykumar
Cheriyan, Binoy Varghese
description Anxiety disorders are common worldwide and novel compounds are investigated for anxiolytic effect. A few studies have demonstrated the anxiolytic-like activity of natural and synthetic flavonoids. 5-methoxyflavone, a synthetic flavone derivative, has been reported to exhibit central nervous system depressant (sedative-hypnotic) effect in an earlier study. The present study was designed to investigate whether 5-methoxyflavone possesses anxiolytic-like activity in mice by employing two unconditioned models of anxiety such as elevated plus maze and light-dark box test. The possible role played by GABAergic (GABAA) and serotonergic (5HT1A) systems in the anxiolytic-like effect of 5-methoxyflavone was also investigated in the elevated plus maze test. Molecular docking studies were performed to ascertain the interaction of 5-methoxyflavone with GABAA (α2 subunit-containing) and 5HT1A receptors. 5-methoxyflavone treatment in mice (10, 20 or 40 mg/kg, i.p) increased the number of entries and time spent in the open arms in an elevated plus maze (p < 0.001). In the light-dark box test a significant increase in the time spent in light compartment (p < 0.001) and prolonged latency to enter the dark compartment (p < 0.01) were also observed. Pretreatment of mice with 5HT1A antagonist pindolol (10 mg/kg, i.p) or GABAA antagonist bicuculline (2 mg/kg, i.p) significantly attenuated the effect of 5-methoxyflavone in the elevated plus maze test. In silico studies provided evidences for good binding affinity of 5-methoxyflavone towards GABAA (α2 subunit-containing) and serotonergic (5HT1A) receptors by H-bond interactions. In conclusion, the present study identified a novel anxiolytic-like effect of 5-methoxyflavone involving GABAergic and serotonergic mechanisms.
doi_str_mv 10.1016/j.euroneuro.2020.05.009
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2414012372</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0924977X20301838</els_id><sourcerecordid>2414012372</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-3aee607c3efafd597597167139a25b2d59fa30f9cb230bfbdeeba572f4295363</originalsourceid><addsrcrecordid>eNqFUctu1TAQtRCVuLR8A16ySfAjiW-WoYKCVIlNF91ZjjOmc0niYvuGZtdfQPwhX4LTi9hWGs14js451ugQ8pazkjPevD-UcAx-3lopmGAlq0vG2hdkx_dKFmrfiJdkx1pRFa1St6_I6xgPjPFaynZHfnXzA_pxTWj_PP4e8TtQYxMumFbqHa0zOEG68w-rG82Sv6E40wkt0J-Y7vKy-HGBCea00a-6Dx2Eb2ipmQcaIfiUJU9AXGOCKdJiM1hw8U-U_I44ovUUFhxgthAvyJkzY4Q3_-Y5ufn08ebyc3H99erLZXddWFntUyENQMOUleCMG-pW5eKN4rI1ou5FRpyRzLW2F5L1rh8AelMr4SrR1rKR5-TdyfY--B9HiElPGC2Mo5nBH6MWFa8YF1KJTFUnqg0-xgBO3wecTFg1Z3rLQB_0_wz0loFmtc4ZZGV3UkI-ZEEIOlrcrhwwgE168Pisx1_JhJpI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2414012372</pqid></control><display><type>article</type><title>Anxiolytic–like activity of 5–methoxyflavone in mice with involvement of GABAergic and serotonergic systems - in vivo and in silico evidences</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Shanmugasundaram, Jaikumar ; Subramanian, Viswanathan ; Nadipelly, Jagan ; Kathirvelu, Parimala ; Sayeli, Vijaykumar ; Cheriyan, Binoy Varghese</creator><creatorcontrib>Shanmugasundaram, Jaikumar ; Subramanian, Viswanathan ; Nadipelly, Jagan ; Kathirvelu, Parimala ; Sayeli, Vijaykumar ; Cheriyan, Binoy Varghese</creatorcontrib><description>Anxiety disorders are common worldwide and novel compounds are investigated for anxiolytic effect. A few studies have demonstrated the anxiolytic-like activity of natural and synthetic flavonoids. 5-methoxyflavone, a synthetic flavone derivative, has been reported to exhibit central nervous system depressant (sedative-hypnotic) effect in an earlier study. The present study was designed to investigate whether 5-methoxyflavone possesses anxiolytic-like activity in mice by employing two unconditioned models of anxiety such as elevated plus maze and light-dark box test. The possible role played by GABAergic (GABAA) and serotonergic (5HT1A) systems in the anxiolytic-like effect of 5-methoxyflavone was also investigated in the elevated plus maze test. Molecular docking studies were performed to ascertain the interaction of 5-methoxyflavone with GABAA (α2 subunit-containing) and 5HT1A receptors. 5-methoxyflavone treatment in mice (10, 20 or 40 mg/kg, i.p) increased the number of entries and time spent in the open arms in an elevated plus maze (p &lt; 0.001). In the light-dark box test a significant increase in the time spent in light compartment (p &lt; 0.001) and prolonged latency to enter the dark compartment (p &lt; 0.01) were also observed. Pretreatment of mice with 5HT1A antagonist pindolol (10 mg/kg, i.p) or GABAA antagonist bicuculline (2 mg/kg, i.p) significantly attenuated the effect of 5-methoxyflavone in the elevated plus maze test. In silico studies provided evidences for good binding affinity of 5-methoxyflavone towards GABAA (α2 subunit-containing) and serotonergic (5HT1A) receptors by H-bond interactions. In conclusion, the present study identified a novel anxiolytic-like effect of 5-methoxyflavone involving GABAergic and serotonergic mechanisms.</description><identifier>ISSN: 0924-977X</identifier><identifier>EISSN: 1873-7862</identifier><identifier>DOI: 10.1016/j.euroneuro.2020.05.009</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>5-methoxyflavone ; Anxiolytic-like activity ; Docking ; GABAA (α2 subunit-containing) receptor ; Serotonergic (5-HT1A) receptor</subject><ispartof>European neuropsychopharmacology, 2020-07, Vol.36, p.100-110</ispartof><rights>2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c348t-3aee607c3efafd597597167139a25b2d59fa30f9cb230bfbdeeba572f4295363</citedby><cites>FETCH-LOGICAL-c348t-3aee607c3efafd597597167139a25b2d59fa30f9cb230bfbdeeba572f4295363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Shanmugasundaram, Jaikumar</creatorcontrib><creatorcontrib>Subramanian, Viswanathan</creatorcontrib><creatorcontrib>Nadipelly, Jagan</creatorcontrib><creatorcontrib>Kathirvelu, Parimala</creatorcontrib><creatorcontrib>Sayeli, Vijaykumar</creatorcontrib><creatorcontrib>Cheriyan, Binoy Varghese</creatorcontrib><title>Anxiolytic–like activity of 5–methoxyflavone in mice with involvement of GABAergic and serotonergic systems - in vivo and in silico evidences</title><title>European neuropsychopharmacology</title><description>Anxiety disorders are common worldwide and novel compounds are investigated for anxiolytic effect. A few studies have demonstrated the anxiolytic-like activity of natural and synthetic flavonoids. 5-methoxyflavone, a synthetic flavone derivative, has been reported to exhibit central nervous system depressant (sedative-hypnotic) effect in an earlier study. The present study was designed to investigate whether 5-methoxyflavone possesses anxiolytic-like activity in mice by employing two unconditioned models of anxiety such as elevated plus maze and light-dark box test. The possible role played by GABAergic (GABAA) and serotonergic (5HT1A) systems in the anxiolytic-like effect of 5-methoxyflavone was also investigated in the elevated plus maze test. Molecular docking studies were performed to ascertain the interaction of 5-methoxyflavone with GABAA (α2 subunit-containing) and 5HT1A receptors. 5-methoxyflavone treatment in mice (10, 20 or 40 mg/kg, i.p) increased the number of entries and time spent in the open arms in an elevated plus maze (p &lt; 0.001). In the light-dark box test a significant increase in the time spent in light compartment (p &lt; 0.001) and prolonged latency to enter the dark compartment (p &lt; 0.01) were also observed. Pretreatment of mice with 5HT1A antagonist pindolol (10 mg/kg, i.p) or GABAA antagonist bicuculline (2 mg/kg, i.p) significantly attenuated the effect of 5-methoxyflavone in the elevated plus maze test. In silico studies provided evidences for good binding affinity of 5-methoxyflavone towards GABAA (α2 subunit-containing) and serotonergic (5HT1A) receptors by H-bond interactions. In conclusion, the present study identified a novel anxiolytic-like effect of 5-methoxyflavone involving GABAergic and serotonergic mechanisms.</description><subject>5-methoxyflavone</subject><subject>Anxiolytic-like activity</subject><subject>Docking</subject><subject>GABAA (α2 subunit-containing) receptor</subject><subject>Serotonergic (5-HT1A) receptor</subject><issn>0924-977X</issn><issn>1873-7862</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFUctu1TAQtRCVuLR8A16ySfAjiW-WoYKCVIlNF91ZjjOmc0niYvuGZtdfQPwhX4LTi9hWGs14js451ugQ8pazkjPevD-UcAx-3lopmGAlq0vG2hdkx_dKFmrfiJdkx1pRFa1St6_I6xgPjPFaynZHfnXzA_pxTWj_PP4e8TtQYxMumFbqHa0zOEG68w-rG82Sv6E40wkt0J-Y7vKy-HGBCea00a-6Dx2Eb2ipmQcaIfiUJU9AXGOCKdJiM1hw8U-U_I44ovUUFhxgthAvyJkzY4Q3_-Y5ufn08ebyc3H99erLZXddWFntUyENQMOUleCMG-pW5eKN4rI1ou5FRpyRzLW2F5L1rh8AelMr4SrR1rKR5-TdyfY--B9HiElPGC2Mo5nBH6MWFa8YF1KJTFUnqg0-xgBO3wecTFg1Z3rLQB_0_wz0loFmtc4ZZGV3UkI-ZEEIOlrcrhwwgE168Pisx1_JhJpI</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Shanmugasundaram, Jaikumar</creator><creator>Subramanian, Viswanathan</creator><creator>Nadipelly, Jagan</creator><creator>Kathirvelu, Parimala</creator><creator>Sayeli, Vijaykumar</creator><creator>Cheriyan, Binoy Varghese</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202007</creationdate><title>Anxiolytic–like activity of 5–methoxyflavone in mice with involvement of GABAergic and serotonergic systems - in vivo and in silico evidences</title><author>Shanmugasundaram, Jaikumar ; Subramanian, Viswanathan ; Nadipelly, Jagan ; Kathirvelu, Parimala ; Sayeli, Vijaykumar ; Cheriyan, Binoy Varghese</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-3aee607c3efafd597597167139a25b2d59fa30f9cb230bfbdeeba572f4295363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>5-methoxyflavone</topic><topic>Anxiolytic-like activity</topic><topic>Docking</topic><topic>GABAA (α2 subunit-containing) receptor</topic><topic>Serotonergic (5-HT1A) receptor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shanmugasundaram, Jaikumar</creatorcontrib><creatorcontrib>Subramanian, Viswanathan</creatorcontrib><creatorcontrib>Nadipelly, Jagan</creatorcontrib><creatorcontrib>Kathirvelu, Parimala</creatorcontrib><creatorcontrib>Sayeli, Vijaykumar</creatorcontrib><creatorcontrib>Cheriyan, Binoy Varghese</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European neuropsychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shanmugasundaram, Jaikumar</au><au>Subramanian, Viswanathan</au><au>Nadipelly, Jagan</au><au>Kathirvelu, Parimala</au><au>Sayeli, Vijaykumar</au><au>Cheriyan, Binoy Varghese</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anxiolytic–like activity of 5–methoxyflavone in mice with involvement of GABAergic and serotonergic systems - in vivo and in silico evidences</atitle><jtitle>European neuropsychopharmacology</jtitle><date>2020-07</date><risdate>2020</risdate><volume>36</volume><spage>100</spage><epage>110</epage><pages>100-110</pages><issn>0924-977X</issn><eissn>1873-7862</eissn><abstract>Anxiety disorders are common worldwide and novel compounds are investigated for anxiolytic effect. A few studies have demonstrated the anxiolytic-like activity of natural and synthetic flavonoids. 5-methoxyflavone, a synthetic flavone derivative, has been reported to exhibit central nervous system depressant (sedative-hypnotic) effect in an earlier study. The present study was designed to investigate whether 5-methoxyflavone possesses anxiolytic-like activity in mice by employing two unconditioned models of anxiety such as elevated plus maze and light-dark box test. The possible role played by GABAergic (GABAA) and serotonergic (5HT1A) systems in the anxiolytic-like effect of 5-methoxyflavone was also investigated in the elevated plus maze test. Molecular docking studies were performed to ascertain the interaction of 5-methoxyflavone with GABAA (α2 subunit-containing) and 5HT1A receptors. 5-methoxyflavone treatment in mice (10, 20 or 40 mg/kg, i.p) increased the number of entries and time spent in the open arms in an elevated plus maze (p &lt; 0.001). In the light-dark box test a significant increase in the time spent in light compartment (p &lt; 0.001) and prolonged latency to enter the dark compartment (p &lt; 0.01) were also observed. Pretreatment of mice with 5HT1A antagonist pindolol (10 mg/kg, i.p) or GABAA antagonist bicuculline (2 mg/kg, i.p) significantly attenuated the effect of 5-methoxyflavone in the elevated plus maze test. In silico studies provided evidences for good binding affinity of 5-methoxyflavone towards GABAA (α2 subunit-containing) and serotonergic (5HT1A) receptors by H-bond interactions. In conclusion, the present study identified a novel anxiolytic-like effect of 5-methoxyflavone involving GABAergic and serotonergic mechanisms.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.euroneuro.2020.05.009</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0924-977X
ispartof European neuropsychopharmacology, 2020-07, Vol.36, p.100-110
issn 0924-977X
1873-7862
language eng
recordid cdi_proquest_miscellaneous_2414012372
source ScienceDirect Freedom Collection 2022-2024
subjects 5-methoxyflavone
Anxiolytic-like activity
Docking
GABAA (α2 subunit-containing) receptor
Serotonergic (5-HT1A) receptor
title Anxiolytic–like activity of 5–methoxyflavone in mice with involvement of GABAergic and serotonergic systems - in vivo and in silico evidences
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A20%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anxiolytic%E2%80%93like%20activity%20of%205%E2%80%93methoxyflavone%20in%20mice%20with%20involvement%20of%20GABAergic%20and%20serotonergic%20systems%20-%20in%20vivo%20and%20in%20silico%20evidences&rft.jtitle=European%20neuropsychopharmacology&rft.au=Shanmugasundaram,%20Jaikumar&rft.date=2020-07&rft.volume=36&rft.spage=100&rft.epage=110&rft.pages=100-110&rft.issn=0924-977X&rft.eissn=1873-7862&rft_id=info:doi/10.1016/j.euroneuro.2020.05.009&rft_dat=%3Cproquest_cross%3E2414012372%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c348t-3aee607c3efafd597597167139a25b2d59fa30f9cb230bfbdeeba572f4295363%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2414012372&rft_id=info:pmid/&rfr_iscdi=true